Post by A.forall

5,496 followers

We’re expanding our US presence: A.forall has acquired four FDA-approved injectable generics and two promising late-stage products from Provepharm’s US portfolio. With this, we considerably extend our marketed portfolio in the US, the world's largest pharmaceutical market. This acquisition is a major step forward in our renewed focus on high-quality generics. It brings scale, relevance and a broader platform to pursue what matters most: #MakingAffordableMedicinesAvailableToAll 🎥 Hear more from our CEO Steen Vangsgaard in this short video. 📄 Read the full press release: https://lnkd.in/eyAJ9jnq #FocusToGrow #GenericExcellence #USGenerics #PharmaNews #AFORALL #FocusToMakeADifference #GlobalHealthcare #CPHI2025

Post content

Video Content